Channel Robotics announced that it has raised $4.6 million in total funding to advance its handheld AI-enabled endoscopic robotic platform.
The company recently closed a $2.5 million Seed+ financing round led by True Ventures. The round follows Channel Robotics’ $2.1 million seed financing, which included participation from Defined VC and Old Line Capital Partners.
Channel Robotics said the new funding will support continued product development, regulatory advancement, and preparation for commercialization.
The company is developing a patented handheld endoscopic robotic platform designed to deliver robotic-level dexterity through existing flexible endoscopes. The platform is intended to expand access to advanced endoscopic procedures by eliminating the need for large, capital-intensive robotic systems.
Channel Robotics said its technology is designed to support use across hospitals, ambulatory surgery centers, and community practice settings.
The financing will support continued refinement and validation of the company’s prototype platform, expansion of engineering and product development efforts, preparation for an FDA submission targeted for 2027, advancement of manufacturing and quality systems, and commercial launch preparation following regulatory clearance.
Channel Robotics is based in San Diego and was founded by physician-scientist Philip Weissbrod and roboticist Michael Yip. The company is focused on creating scalable robotic solutions that integrate into existing clinical workflows.
The company’s technology combines robotic instrumentation, intuitive control systems, and artificial intelligence to enable more precise and accessible endoscopic interventions.
KEY QUOTES:
“Our mission is to democratize access to advanced endoscopic robotics. This financing enables us to continue building a platform that can bring sophisticated robotic capabilities to physicians in a practical, scalable, and cost-effective way.”
Michael Yip, Co-Founder of Channel Robotics
“Mike and Philip are a rare combination of deep clinical experience and expertise combined with robotics which enables practical solutions for an unprecedented number of clinics and physicians. Their innovation solves serious robotics challenges in service of human health, and we are honored to be a part of their journey.”
Rohit Sharma, Partner at True Ventures
“With the support of True Ventures and our existing investors, we are well-positioned to accelerate development and bring this technology to clinicians and patients. We believe the future of endoscopic robotics will be defined by solutions that are more accessible, easier to adopt, and capable of reaching far more patients than traditional robotic systems.”
Philip Weissbrod, Co-Founder and CEO of Channel Robotics
